[1]Lee Y, Ahn C, Han J,et al. The nuclear RNase Ⅲ Drosha initiates microRNA processing.Nature, 2003.425(6956):415-419. [2]He L,Hannon GJ. MicroRNAs:small RNAs with a big role in gene regulation.Nat Rev Genet, 2004.5(7):522-531. [3] Yi R,Qin Y,Macara IG，Cullen BR. Exportin -5 mediates the nuclear export of pre-miRNAs and short hairpin RNAs.Genes Dev, 2003.17(24):3011-3016. [4]Tang G.siRNA and miRNAs :An insight into RISCs.Trends Biochem Sci, 2005.30(2):106-114. [5] Sunkar R ,Girke T，Jain PK,Zhu JK. Cloning and characterization of microRNAs from rice.Plant Cell, 2005.17(5):1397-1411. [6] Kim J,Krichevsky A,et al. Idetification of many microRNAs that copurify with polyribosomes in mammalian neuron.Proc Natl Acad Sci USA, 2004.101(1):360-365. [7] . Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15–20. [PubMed: 15652477] [8] Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009;19:92–105. [PubMed: 18955434] [9]王震英 徐秀莲 陈楠 ，microRNA与黑素瘤.国际皮肤性病学杂志, 2009年7月 第35卷第4期. [10] Felicetti F，Errico MC，Bottero L，et a1．The promyelocytic leukemia zinc finger-microRNA-221／-222 pathway controls melanoma progression through multiple oncogenic mechanisms．Cancer Res，2008，68(8)：2745-2754． [11].Felicetti F，Errico MC，Segnalini P，et a1．MicroRNA-221 and -222 pathway controls melanoma progression．Expert Rev Anti-cancer Ther，2008，8(1 1)：1759-1765． [12]Igoucheva O，Alexeev V．MicroRNA-dependent regulation of cKit in cutaneous melanoma．Biochem Biophys Res Commun,2009，379(3)：790-794．1] [13]．Bemis LT，Chen R,Amato CM,et al.MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines．Cancer Res．2008．68(5)：1362-1368． [14].Lodygin D，Tarasov V，Epanchintsev A,et a1．Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer．Cell Cycle．2008，7(16)：259l-2600． [15] Yan D，Zhou X，Chen X,et a1．MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregnlation of c-Met．Invest Ophthalmol Vis Sci．2009．50(4)：1559． [16]Migliore C，Petrelli A,Ghiso E，et a1．MicroRNAs impair MET-mediated invasive growth．Cancer Res，2008.68(24)：10128-10136． [17] Worley LA，Long MD，Ollken MD，et a1．MicroRNAs associated、with metastasis in uveal melanoma identified by multiplexcd microarray profiling．Melanoma Res．2008．18(3)：184-190． [18] Sehultz J，Lorenz P，Gross G，et a1．MicroRNA let-7b targets important celll cycle molecules in malignant melanomacells and interferes with anchomge-independent growth．Cell Res，2008，18(5)：549-557． [19] Mailer Dw，Bosserhoff AK integrin beta 3 expression is regufated by let-7a miRNA in malignant melanoma．Oncogene，2008．27(52)：6698-6706． [20]. Chen J, Feilotter HE, Zhang X,et al. MicroRNA-193b Represses Cell Proliferationand Regulates Cyclin D1 in Melanoma. Am J Pathol. 2010 Mar 19. [21]Yu J，Ryan DG；，Getsios S，et a1．MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia．Proc Natl Acad Sci U S A，2008，105(49)：19300-19305． [22]. Sand M, Gambichler T, Skrygan M, et al.Expression Levels of the microRNA Processing Enzymes Drosha and Dicer in Epithelial Skin Cancer. Cancer Invest. 2010 Mar 8. [23]. Skalsky RL, SamolsMA, Plaisance KB. Kaposi’s sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol. 2007;81:12836–45. [24] Gottwein E, Cai X, Cullen BR. A novel assay for viral microRNA function identi?es a single nucleotide polymorphism that affects Drosha processing. J Virol 2006;80:5321–6. [25] Tam W, Ben-Yehuda D, Hayward WS. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 1997;17:1490–1502. [26] Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD. Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 1994;96:146–151. [27]. Sonkoly E, Wei T, Janson PC, Saaf A, Lundeberg L, Tengvall-Linder M et al. MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis．PLos One ，2007，2 ( 7) ：610 - 615 ． [28].Dai Y，Huang YS，Tang M．Mieroarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients．Lupus，2007．16(12)：939-946． [29].李海涛，杨蓉娅，樊昕，[会议论文] 2009 . 2009年京津冀地区皮肤科学术年会论文集. [30].Maurer B, Stanczyk J, Jüngel A,et al. miR-29 is a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 2010 Mar 3. [31] 袁晋 傅雯雯 吴文育.斑秃治疗的研究进展. 中国现代医药杂志,2008年11月第 10卷第11期 [32] 蔡晓伟 李 惠.IFN-γ、 IL-10与斑秃关系的初步研究. 华南国防医学杂志,2008年第22卷 第6期 [33] 张西克，高顺强.斑秃与 CTLA-4基因外显子1A/G 49多态性研究.实用心脑肺血管病杂志,2009年 11月第 17卷第 11 期 [34].Goodarzi HR, Abbasi A, Saffari M, et al.MicroRNAs take part in pathophysiology and pathogenesis of Male Pattern Baldness.Mol Biol Rep. 2009 Oct 10. [35] Eberhart JK, He X, Swartz ME, Yan YL, Song H, Boling TC, et al. MicroRNA Mir-140 modulates Pdgf signaling during palatogenesis. Nat Genet 2008;40:290–8. [36].Sun Q, Zhang Y, Yang G, Chen X, Zhang Y, Cao G, et al. Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res 2008;36:2690–9. [37] Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006;103:12481–6. [38] Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007;179:5082–9. [39].Rozman P．Bolta Z．Use of platelet growth factors in treating wounds and soft-tissue injuries．Acta Dermamvenerol Alp Panonica Adriat．2007．16(4)：156-165． [40].Gu J，Iyer VR．P13K signaling and miRNA expression duringthe response of quiescent human fibroblasts to distinct proliferative stimuli．Genome Bio1．2006．7(5)：R42． [41].Shilo S．Roy S，Khanna S．MicroRNA in cutaneous wound healing：a new paradigm．DNA Cell Biol，2007，26(4)：227．